In the TROPiCS-02 phase 3 study, neutropenic colitis occurred in 0.5% of patients with hormone receptor-positive/HER2-negative advanced breast cancer, of note, one patient death was related to septic shock from SG associated neutropenic colitis (Rugo et al., 2022d). This evidence concerns the gene ERBB2 and colitis.